{"id":"https://genegraph.clinicalgenome.org/r/b7ee4cbb-3011-4d6a-b8c5-97d4a2b028c4v1.8","type":"EvidenceStrengthAssertion","dc:description":["*HNRNPK* was first reported in relation to autosomal dominant neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome (Au-Kline syndrome) in 2015 (Au et al., PMID: 26173930). Au-Kline syndrome (AKS) is caused by *de novo* variants in *HNRNPK*, leading to variable dysmorphic features, cardiac malformations, developmental delay, and intellectual disability. Multiple patients diagnosed with AKS were initially diagnosed with Kabuki syndrome.\n\nTen variants (all *de novo* loss of function caused by missense, nonsense, frameshift, and splice variants) that have been reported in 10 probands in 5 publications (PMIDs: 26173930, 26954065, 28374925, 28771707, 29904177) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is known to be loss of function.\n\nThis gene-disease relationship is also supported by the biochemical function of HNRNPK in osteoclast differentiation as the phenotype involves skeletal abnormalities, including craniosynostosis (PMID: 26638989). \n\nIn summary, there is definitive evidence to support the relationship between *HNRNPK* and autosomal dominant Au-Kline syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the General Gene Curation Expert Panel in 2016. It was reevaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on December 21, 2021. As a result of this reevaluation, the classification increased from Moderate to Definitive with the addition of new literature (SOP Version 8).\n","*HNRNPK* was first reported in relation to autosomal dominant neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome (Au-Kline syndrome) in 2015 (Au et al., PMID: 26173930). Au-Kline syndrome (AKS) is caused by de novo variants in *HNRNPK*, leading to variable dysmorphic features, cardiac malformations, developmental delay, and intellectual disability. Multiple patients diagnosed with AKS were initially diagnosed with Kabuki syndrome. Ten variants (all *de novo* loss of function caused by missense, nonsense, frameshift, and splice variants) that have been reported in 10 probands in 5 publications (PMIDs: 26173930, 26954065, 28374925, 28771707, 29904177) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is known to be loss of function.\n\nThis gene-disease relationship is also supported by the biochemical function of *HNRNPK* in osteoclast differentiation as the phenotype involves skeletal abnormalities, including craniosynostosis (PMID: 26638989). \n\nIn summary, there is definitive evidence to support the relationship between *HNRNPK* and autosomal dominant Au-Kline syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the General Gene Curation Expert Panel GCEP in 2016. It was reevaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on December 20, 2021. As a result of this reevaluation, the classification increased from Moderate to Definitive with the addition of new literature (SOP Version 8).\n"],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b7ee4cbb-3011-4d6a-b8c5-97d4a2b028c4","GCISnapshot":"https://genegraph.clinicalgenome.org/r/f1adc74c-9bbc-48fc-bbbf-1159c0944108","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/f1adc74c-9bbc-48fc-bbbf-1159c0944108_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":["2021-12-21T11:00:00.000Z","2021-12-20T07:00:00.000Z"],"role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/f1adc74c-9bbc-48fc-bbbf-1159c0944108_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-10-02T17:14:44.234Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1adc74c-9bbc-48fc-bbbf-1159c0944108_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57efa0ea-767b-4e27-8fec-ee2a7b88f568","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57efa0ea-767b-4e27-8fec-ee2a7b88f568_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29904177","allele":{"id":"https://genegraph.clinicalgenome.org/r/f24d5caf-025e-4d0c-8a46-061dd0160eb8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002140.4(HNRNPK):c.1009delG","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658797216"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ba0c17f8-ecc1-4393-ae21-3511fb54a0ab","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba0c17f8-ecc1-4393-ae21-3511fb54a0ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26173930","allele":{"id":"https://genegraph.clinicalgenome.org/r/798afe31-584d-4af5-8137-edf007d1b1e3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_031263.4(HNRNPK):c.953+1dup","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA278923"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/25f66c19-50cd-402d-8ef7-dacd179ff6c2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25f66c19-50cd-402d-8ef7-dacd179ff6c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29904177","allele":{"id":"https://genegraph.clinicalgenome.org/r/79afa8d9-7033-4548-b5da-5ea4cc076b6c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002140.4(HNRNPK):c.1094delG","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658797215"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b74f1fa6-ffea-4fc4-8b0c-0c91b983f664","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b74f1fa6-ffea-4fc4-8b0c-0c91b983f664_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26954065","allele":{"id":"https://genegraph.clinicalgenome.org/r/12d1e15c-0dc1-4684-a56a-2327c86e19a6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_031263.4(HNRNPK):c.931_932insTT (p.Pro311LeufsTer40)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/221225"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/81a27d4b-20f5-4bf2-9ec7-6b98e5608e38","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81a27d4b-20f5-4bf2-9ec7-6b98e5608e38_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29904177","allele":{"id":"https://genegraph.clinicalgenome.org/r/a32bd29e-1112-465c-a081-5c183efbb622","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_031263.4(HNRNPK):c.1008+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA373922214"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/401dc94a-84c4-4854-9a0a-f0193454ac92","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/401dc94a-84c4-4854-9a0a-f0193454ac92_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26173930","allele":{"id":"https://genegraph.clinicalgenome.org/r/1cdf27c5-20d3-48ea-94e6-9ece366395fa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_031263.4(HNRNPK):c.257G>A (p.Arg86His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/212776"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/401dc94a-84c4-4854-9a0a-f0193454ac92_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"While this sequence change is predicted to alter an amino acid, p.(Arg86His), it occurs in the last codon of exon 5 and is predicted to abolish the splice donor site.\nUsing western blot analysis we assessed protein expression of hn RNPK in proband 2 versus control fibroblasts (Supp. Methods). The hnRNPK protein was significantly decreased in Proband 2, 48.5% of control levels in fibroblasts (P<0.01, Welch's t-test, Figure 1M,N), supporting the predicted impact of the c.257G>A splice variant on HNRNPK gene expression.","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/37d6b4a1-dad4-4f55-9db7-a16b7c5b2931","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37d6b4a1-dad4-4f55-9db7-a16b7c5b2931_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29904177","allele":{"id":"https://genegraph.clinicalgenome.org/r/1bee4afb-26db-4450-a2a9-bb88bdbcac2b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_031263.4(HNRNPK):c.859C>T (p.Arg287Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA373923792"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7ad97fce-ef39-40b1-bdb7-ef8f32445020","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ad97fce-ef39-40b1-bdb7-ef8f32445020_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28374925","allele":{"id":"https://genegraph.clinicalgenome.org/r/998dda33-9868-422f-aef1-c68e66ae0973","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_031263.4(HNRNPK):c.998dup (p.Tyr333Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658797217"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/74080624-da78-41a8-8f13-175f2d0232c2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74080624-da78-41a8-8f13-175f2d0232c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29904177","allele":{"id":"https://genegraph.clinicalgenome.org/r/1768dcce-a325-4607-a240-293b82a90229","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_031263.4(HNRNPK):c.779dup (p.Phe261_Asp262insTer)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10603108"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/aaa45bc7-f1ca-49f1-ad84-31aad5cf6c46","type":"EvidenceLine","dc:description":"The variant was predicted to be pathogenic by in silico prediction tools (SIFT: 0.03, PolyPhen-2: 1.0, MutationTaster: disease causing) and not registered in the in-house exome (n = 575), ExAC, Exome Variant Server, or Human Genomic Variation database. The altered amino residue is highly conserved from lampreys to humans. HNRNPK has 3 K-homology RNA-binding (KH) domains which are responsible for the sequence-specific RNA and DNA binding. By in silico structural modeling by the Phyre2 server, L155 is located in the first turn of helix α1, and L155P mutation was thought to affect a hydrophobic core packing involving the side chain of Leu155 and stability of helix α1, thereby impairing the interactions of the protein with DNA or RNA.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aaa45bc7-f1ca-49f1-ad84-31aad5cf6c46_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28771707","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4bd4945-9779-40b9-97d5-6ffdd698859c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_031263.4(HNRNPK):c.464T>C (p.Leu155Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/625163"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/aaa45bc7-f1ca-49f1-ad84-31aad5cf6c46_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant was predicted to be pathogenic by in silico prediction tools (SIFT: 0.03, PolyPhen-2: 1.0, MutationTaster: disease causing) and not registered in the in-house exome (n = 575), ExAC, Exome Variant Server, or Human Genomic Variation database. The altered amino residue is highly conserved from lampreys to humans. HNRNPK has 3 K-homology RNA-binding (KH) domains which are responsible for the sequence-specific RNA and DNA binding. By in silico structural modeling by the Phyre2 server, L155 is located in the first turn of helix α1, and L155P mutation was thought to affect a hydrophobic core packing involving the side chain of Leu155 and stability of helix α1, thereby impairing the interactions of the protein with DNA or RNA.","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/f1adc74c-9bbc-48fc-bbbf-1159c0944108_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1adc74c-9bbc-48fc-bbbf-1159c0944108_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e6ae236-33f4-4140-9afc-85a456b605c5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/895cead3-6d83-42f5-8600-cc2903d1bb06","type":"Finding","dc:description":"As the phenotype involves skeletal abnormalities, including craniosynostosis, this may be relevant.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26638989","rdfs:label":"Fan 2015 Function 1","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Definitive","sequence":11923,"specifiedBy":"GeneValidityCriteria8","strengthScore":12.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Qg3buleOoy8","type":"GeneValidityProposition","disease":"obo:MONDO_0018681","gene":"hgnc:5044","modeOfInheritance":"obo:HP_0000006"},"version":"1.8","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_f1adc74c-9bbc-48fc-bbbf-1159c0944108-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}